Patents by Inventor Neal Frederick Osborne

Neal Frederick Osborne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of cephalosporin compounds and synthetic intermediates
    Patent number: 7355040
    Abstract: There is provided a process for the preparation of a compound according to Formula (II): which includes the step of cyclizing a compound of Formula (III): wherein R1, R2, R3, R4, X and m have meanings which are given in the description.
    Type: Grant
    Filed: November 22, 2004
    Date of Patent: April 8, 2008
    Inventors: Desmond John Best, George Burton, Brian Charles Gasson, Neal Frederick Osborne, Graham Walker
  • Process for the preparation of cephalosporin compounds and synthetic intermediates
    Patent number: 6825344
    Abstract: There is provided a process for the preparation of a compound according to Formula (II): which includes the step of cyclising a compound of Formula (III): wherein R1, R2, R3, R4, X and m have meanings which are given in the description.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: November 30, 2004
    Assignee: Pfizer Inc.
    Inventors: Desmond John Best, George Burton, Brian Charles Gasson, Neal Frederick Osborne, Graham Walker
  • Novel process
    Publication number: 20020058806
    Abstract: There is provided a process for the preparation of a compound according to Formula (II): 1
    Type: Application
    Filed: July 30, 2001
    Publication date: May 16, 2002
    Inventors: Desmond John Best, George Burton, Brian Charles Gasson, Neal Frederick Osborne, Graham Walker
  • Methods using the staphylococcus aureus glycyl tRNA synthetase crystalline structure
    Patent number: 6197495
    Abstract: A novel Staphylococcus glycyl tRNA synthetase crystalline structure is identified. Also disclosed are methods of identifying inhibitors of these synthetases and/or active sites, and inhibitors identified by these methods.
    Type: Grant
    Filed: May 10, 1998
    Date of Patent: March 6, 2001
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham plc
    Inventors: Xiayang Qiu, Neal Frederick Osborne, Christine Mary Richardson, Cheryl A. Janson
  • Methods using the Staphylococcus aureus glycyl tRNA synthetase crystalline structure
    Patent number: 6037117
    Abstract: A novel Staphylococcus glycyl tRNA synthetase crystalline structure is identified. Also disclosed are methods of identifying inhibitors of these synthetases and/or active sites, and inhibitors identified by these methods.
    Type: Grant
    Filed: January 31, 1997
    Date of Patent: March 14, 2000
    Assignees: Smithkline Beecham Corporation, Smithkline Beecham plc
    Inventors: Xiayang Qiu, Neal Frederick Osborne, Christine Mary Richardson, Cheryl A. Janson
  • 7-.beta.-Acylamino-ceph-3-ems and salts and esters therefor
    Patent number: 3966718
    Abstract: Antimicrobially active substituted ceph-3-ems, procedure for their preparation and intermediates for use in the procedure are described. These cephalosporins are characterized by having a 2- or 3- pyridyl group attached to the carbon atom of the methylene group in the 3-position by a carbon-carbon bond and not a carbon-nitrogen bond.
    Type: Grant
    Filed: January 17, 1974
    Date of Patent: June 29, 1976
    Assignee: Beecham Group Limited
    Inventors: Edward George Brain, Neal Frederick Osborne